The European Medicines Agency has updated the ICH Q2(R2) Guideline on validation of analytical procedures. The update final adoption was in December 2023 and will come into effect from 14 June 2024. This update is significant for pharmaceutical professionals and represents progress in the analytical procedure validation field. The revised guideline includes new technologies and definitions, aiming to bridge differences among regulatory authorities. It also incorporates principles from ICH Q8-Q10 and has an inter-relationship with ICH Q14.
You can read the complete updated guideline here: ICH Q2 (R2)